Ti-Mediated Synthesis of Aminocyclopropyl-Substituted Carbohydrates
(1S)-1-C-(1-Aminocyclopropyl)-1,2:3,4-di-O-isopropylidene-
FULL PAPER
= 8.1 Hz, 1 H), 4.03–4.18 (m, 3 H) ppm. 13C NMR (CDCl3,
D
-
threitol (8): Yellow oil (0.146 g, 57%). Rf = 0.26 (diethyl ether/NEt3, 62.5 MHz): δ = 14.2, 19.5, 21.2, 26.1, 26.6, 27.3, 27.7, 36.0, 66.6,
98:2). [α]2D0 = –7.3 (c = 0.99, CHCl3). 1H NMR (CDCl3, 500 MHz):
δ = 0.53 (ddd, J = 9.8, 6.0, 4.3 Hz, 1 H), 0.63 (ddd, J = 9.8, 6.0,
3.7 Hz, 1 H), 0.69 (ddd, J = 9.2, 5.7, 4.3 Hz, 1 H), 0.75 (ddd, J =
9.2, 5.7, 3.7 Hz, 1 H), 1.39 (s, 3 H), 1.43 (s, 3 H), 1.45 (s, 3 H), 1.49
(s, 3 H), 1.60 (brs, 2 H, NH2), 3.41 (d, J = 8.1 Hz, 1 H), 3.93 (t, J
= 8.1 Hz, 1 H), 4.03 (dd, J = 8.2, 3.8 Hz, 1 H), 4.08 (dd, J = 8.2,
6.6 Hz, 1 H), 4.14 (ddd, J = 8.1, 6.6, 3.8 Hz, 1 H) ppm. 13C NMR
(CDCl3, 62.5 MHz): δ = 11.4, 14.6, 26.1, 26.6, 27.3, 27.8, 32.7, 66.5,
75.8, 76.8, 80.1, 109.1, 110.0 ppm.
Isomer 12b: Rf = 0.42 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.41 (dd, J = 6.0, 5.7 Hz, 1 H), 0.79–0.93 (m, 2 H),
1.14 (d, J = 6.4 Hz, 3 H), 1.39 (s, 3 H), 1.42 (s, 3 H), 1.43 (s, 3 H),
1.48 (s, 3 H), 1.79 (brs, 2 H, NH2), 3.84 (d, J = 8.4 Hz, 1 H), 3.98
(t, J = 8.4 Hz, 1 H), 4.03–4.18 (m, 3 H) ppm. 13C NMR (CDCl3,
62.5 MHz): δ = 14.8, 20.3, 22.5, 26.2, 26.5, 27.1, 27.8, 35.6, 66.6,
73.8, 75.4, 81.9, 108.8, 109.7 ppm. IR (neat) of 12a and 12b: ν =
˜
75.7, 77.1, 84.0, 109.1, 110.0 ppm. IR (neat): ν = 3368, 2986, 2927,
˜
2984, 2929, 1454, 1375, 1070 cm–1. HRMS (ESI): calcd. for
1597, 1456, 1375, 1158, 1071 cm–1. HRMS (ESI): calcd. for
C14H26NO4 [M + H]+: m/z = 272.1862; found 272.1866.
C13H24NO4 [M + H]+: m/z = 258.1705; found 258.1711.
(1R)-1-C-(1-Aminocyclopropyl)-1,2,4-tri-O-benzyl-3-O-pivaloyl-
D
-
Isomer 12c: Rf = 0.12 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.18 (t, J = 5.5 Hz, 1 H), 0.65 (dd, J = 9.4, 5.5 Hz,
1 H), 0.74–0.89 (m, 1 H), 1.17 (d, J = 6.0 Hz, 3 H), 1.38 (s, 3 H),
erythritol (9): Colourless oil (0.329 g, 62 %). Rf = 0.14 (diethyl
ether/NEt3, 98:2). [α]2D0 = –0.7 (c = 2.03, CHCl3). 1H NMR (CDCl3,
500 MHz): δ = 0.42 (m, 1 H), 0.50 (m, 1 H), 0.74 (m, 2 H), 1.21 1.41 (s, 3 H), 1.43 (s, 3 H), 1.47 (s, 3 H), 1.77 (brs, 2 H, NH2), 3.29
(s, 9 H), 1.80 (brs, 2 H, NH2), 2.85 (d, J = 6.2 Hz, 1 H), 3.83 (d,
J = 5.0 Hz, 2 H), 3.98 (dd, J = 6.2, 3.1 Hz, 1 H), 4.45 (d, J =
10.7 Hz, 1 H), 4.47 (d, J = 10.7 Hz, 1 H), 4.67 (d, J = 11.1 Hz, 1
H), 4.70 (d, J = 11.1 Hz, 1 H), 4.74 (d, J = 11.0 Hz, 1 H), 4.76 (d,
J = 11.0 Hz, 1 H), 5.37 (td, J = 5.0, 3.1 Hz, 1 H) ppm. 13C NMR
(CDCl3, 62.5 MHz): δ = 11.3, 16.5, 27.6, 34.5, 39.3, 68.9, 72.9,
73.7, 74.8, 75.9, 83.2, 85.3, 128.1–128.9 (15 C), 138.5, 138.6, 138.9,
(d, J = 8.4 Hz, 1 H), 3.84 (t, J = 8.4 Hz, 1 Hz), 4.03–4.15 (m, 3 H)
ppm. 13C NMR (CDCl3, 62.5 MHz): δ = 13.1, 17.7, 18.5, 26.1,
26.6, 27.4, 27.7, 36.0, 66.6, 75.9, 77.0, 85.5, 109.0, 109.9 ppm.
Isomer 12d: Rf = 0.12 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.32 (t, J = 4.6 Hz, 1 H), 0.74–0.89 (m, 2 H), 1.17
(d, J = 6.0 Hz, 3 H), 1.38 (s, 3 H), 1.41 (s, 3 H), 1.43 (s, 3 H), 1.47
(s, 3 H), 1.77 (brs, 2 H, NH2), 3.32 (d, J = 8.0 Hz, 1 H), 3.91 (t, J
= 8.0 Hz, 1 H), 3.98 (dd, J = 8.4, 4.0 Hz, 1 H), 4.03–4.15 (m, 2 H)
ppm. 13C NMR (CDCl3, 62.5 MHz): δ = 12.4, 16.1, 20.7, 26.1,
26.6, 27.4, 27.7, 36.0, 66.2, 76.0, 77.2, 85.3, 109.0, 109.9 ppm. IR
178.7 ppm. IR (neat): ν = 3374, 3064, 3031, 2972, 2926, 2870, 1722,
˜
1455, 1284, 1160, 1096 cm–1. HRMS (ESI): calcd. for C33H42NO5
[M + H]+: m/z = 532.3063; found 532.3077.
(4R)-4-C-(1-Aminocyclopropyl)-3-O-benzyl-1,2-O-isopropylidene-α-
(neat) of 12c and 12d: ν = 2987, 2932, 1373, 1249, 1218, 1159,
˜
D
-threofuranose (10): Colourless oil (0.165 g, 54%). Rf = 0.43 (di-
1069 cm–1. HRMS (ESI): calcd. for C14H26NO4 [M + H]+: m/z =
1
ethyl ether/NEt3, 98:2). [α]2D0 = –84.3 (c = 0.79, CHCl3). H NMR
(CDCl3, 500 MHz): δ = 0.41 (ddd, J = 9.7, 5.7, 4.2 Hz, 1 H), 0.56
(ddd, J = 9.7, 5.9, 4.2 Hz, 1 H), 0.69 (ddd, J = 9.8, 5.7, 4.2 Hz, 1
H), 0.73 (ddd, J = 9.8, 5.9, 4.2 Hz, 1 H), 1.33 (s, 3 H), 1.45 (s, 3
272.1862; found 272.1867.
(1S)-1-C-(1-Amino-2-ethylcyclopropyl)-1,2:3,4-di-O-isopropylidene-
D-threitol (13): Treatment of the nitrile 1 (227 mg, 1 mmol) with
H), 2.07 (brs, 2 H, NH2), 3.52 (d, J = 3.6 Hz, 1 H), 3.97 (d, J = nBuMgBr (1.1 mL, 2.2 mmol, 2 in Et2O) in the presence of
3.6 Hz, 2 H), 4.53 (d, J = 11.9 Hz, 1 H), 4.62 (d, J = 3.9 Hz, 1 H), Ti(OiPr)4 (0.33 mL, 1.1 mmol) afforded 13a–b (60 mg, 21%) as a
4.75 (d, J = 11.9 Hz, 1 H), 6.01 (d, J = 3.9 Hz), 7.20–7.30 (m, 5 H) 66:34 mixture of isomers and 13c–d (120 mg, 42%) as a 68:32 mix-
ppm. 13C NMR (CDCl3, 62.5 MHz): δ = 11.4, 15.4, 26.7, 27.3, ture of isomers.
32.8, 72.4, 82.6, 84.5, 85.2, 105.6, 111.8, 128.3 (2 C), 128.7, 129.0
Isomer 13a: Rf = 0.59 (diethyl ether/NEt3 98:2). 1H NMR (CDCl3,
(2 C), 137.6 ppm. IR (neat): ν = 3377, 2986, 2930, 2872, 1599, 1455,
˜
500 MHz): δ = 0.22 (t, J = 5.4 Hz, 1 H), 0.63 (dd, J = 9.1, 5.4 Hz,
1 H), 0.65–0.75 (m, 1 H), 1.00 (t, J = 7.2 Hz, 3 H), 1.38 (s, 3 H),
1.41 (s, 3 H), 1.43 (s, 3 H), 1.46 (s, 3 H), 1.49–1.59 (m, 2 H), 3.33
(d, J = 8.1 Hz, 1 H), 3.90 (t, J = 8.1 Hz, 1 H), 4.01–4.15 (m, 3 H)
ppm. 13C NMR (CDCl3, 62.5 MHz): δ = 14.5, 15.7, 16.4, 21.7,
26.1, 26.6, 27.4, 27.8, 36.3, 66.6, 76.0, 77.0, 85.4, 109.0, 109.9 ppm.
1378, 1216, 1075, 1031 cm–1. HRMS (ESI): calcd. for C17H24NO4
[M + H]+: m/z = 306.1705; found 306.1700.
1-(2,3,5-Tri-O-benzoyl-β-D-ribofuranosyl)cyclopropylamine (11):
Yellow oil (0.276 g, 55 %). Rf = 0.12 (diethyl ether/NEt3, 98:2).
[α]2D0 = +7.3 (c = 3.9, CHCl3). 1H NMR (CDCl3, 500 MHz): δ =
0.67 (m, 3 H), 0.78 (m, 1 H), 1.91 (brs, 2 H, NH2), 3.70 (m, 1 H),
4.61 (m, 1 H), 4.64 (m, 1 H), 4.82 (m, 1 H), 5.80 (m, 2 H), 7.42–
7.43 (m, 4 H), 7.49–7.51 (m, 2 H), 7.52–7.54 (m, 3 H), 7.97–8.02
(m, 4 H), 8.14–8.16 (m, 2 H) ppm. 13C NMR (CDCl3, 62.5 MHz):
δ = 11.1, 14.4, 33.5, 64.6, 72.4, 73.6, 80.2, 88.0, 128.9–130.1 (15 C),
Isomer 13b: Rf = 0.59 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.37 (t, J = 5.2 Hz, 1 H), 0.65–0.75 (m, 2 H), 1.00
(t, J = 7.2 Hz, 3 H), 1.39 (s, 3 H), 1.41 (s, 3 H), 1.43 (s, 3 H), 1.48
(s, 3 H), 1.49–1.59 (m, 2 H), 3.36 (d, J = 8.4 Hz, 1 H), 3.97 (dd, J
= 8.4, 3.7 Hz, 1 H), 4.01–4.15 (m, 3 H) ppm. 13C NMR (CDCl3,
62.5 MHz): δ = 14.5, 14.9, 16.4, 21.7, 26.1, 26.6, 27.4, 27.8, 36.3,
66.3, 75.7, 77.0, 85.1, 109.0, 109.9 ppm. IR (neat) of 13a and 13b:
133.8 (3 C), 165.8, 165.9, 166.7 ppm. IR (neat): ν = 3385, 3064,
˜
3009, 2954, 1717, 1602, 1452, 1315, 1268, 1123 cm–1. HRMS (ESI):
calcd. for C29H28NO7 [M + H]+: m/z = 502.1866; found 502.1863.
ν = 2986, 2931, 1375, 1219, 1157, 1069 cm–1. HRMS (ESI): calcd.
˜
(1S)-1-C-(1-Amino-2-methylcyclopropyl)-1,2:3,4-di-O-isopropyl-
idene-D-threitol (12): Treatment of the nitrile 1 (227 mg, 1 mmol)
for C15H28NO4 [M + H]+: m/z = 286.2018; found 286.2029.
with iPrMgBr (1.1 mL, 2.2 mmol, 2 in Et2O) in the presence of
Ti(OiPr)4 (0.33 mL, 1.1 mmol) afforded 12a–b (50 mg, 18%) as a
60:40 mixture of isomers and 12c–d (110 mg, 41%) as a 78:32 mix-
ture of isomers.
Isomer 13c: Rf = 0.26 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.17 (t, J = 5.5 Hz, 1 H), 0.79 (dd, J = 9.1, 5.5 Hz,
1 H), 0.82–0.92 (m, 1 H), 1.02 (t, J = 7.4 Hz, 3 H), 1.38 (s, 3 H),
1.41 (s, 3 H), 1.44 (s, 3 H), 1.48 (s, 3 H), 1.50–1.57 (m, 2 H), 1.92
(brs, 2 H, NH2), 3.60 (d, J = 8.3 Hz, 1 H), 3.90 (t, J = 8.3 Hz,
Isomer 12a: Rf = 0.42 (diethyl ether/NEt3, 98:2). 1H NMR (CDCl3,
500 MHz): δ = 0.16 (t, J = 5.5 Hz, 1 H), 0.79–0.93 (m, 2 H), 1.14 1 H), 4.03–4.15 (m, 3 H) ppm. 13C NMR (CDCl3, 62.5 MHz): δ =
(d, J = 6.4 Hz, 3 H), 1.39 (s, 3 H), 1.42 (s, 3 H), 1.43 (s, 3 H), 1.48
(s, 3 H), 1.79 (brs, 2 H, NH2), 3.60 (d, J = 8.1 Hz, 1 H), 3.89 (t, J
14.2, 17.9, 22.9, 26.2, 26.6, 27.3, 27.7, 29.3, 36.0, 66.6, 75.7, 76.8,
80.1, 109.0, 110.0 ppm.
Eur. J. Org. Chem. 2005, 5084–5088
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5087